Iran Asks US Supreme Court to Help Protect Its Assets
Iran’s central bank has filed a petition with the U.S. Supreme Court seeking to overturn a lower court ruling that would have transferred Iranian funds to the U.S. and made them potentially available for awards to victims of terrorism.
At issue is the legal interpretation of the Foreign Sovereign Immunities Act. A new brief from the Congressional Research Service provides background on the matter. See Iran’s Central Bank Asks Supreme Court to Consider Whether the Bank’s Assets Abroad are Immune from Attachment to Satisfy Terror Judgments by Jennifer K. Elsea, CRS Legal Sidebar, May 30, 2018.
Other new publications from the Congressional Research Service include the following.
Sidewalks, Streets, and Tweets: Is Twitter a Public Forum?, CRS Legal Sidebar, May 30, 2018
(Robo)Call Me Maybe: Robocalls to Wireless Phones Under the Telephone Consumer Protection Act, CRS Legal Sidebar, May 29, 2018
The Role of the Office of National Drug Control Policy (ONDCP), CRS Insight, June 1, 2018
The House Journal: Origin, Purpose, and Approval, May 31, 2018
Federal Grants and Loans for State and Local Emergency Communications Projects: Frequently Asked Questions, June 1, 2018
Federal Aviation Administration (FAA) Reauthorization Issues and Debate in the 115th Congress, May 29, 2018
U.S. Department of State Personnel: Background and Selected Issues for Congress, May 18, 2018
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.